Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations

被引：2
作者：
Arns, W. [1 ]
Budde, K. [2 ]
Eitner, F. [3 ]
Gwinner, W. [4 ]
Hugo, C. [5 ]
Pressmar, K. [6 ]
Weimann, A. [7 ]
Witzke, O. [8 ]
机构：
[1] Univ Witten Herdecke, Klinikum Koln Merheim, Med Klin Nephrol 1, Witten, Germany
[2] Charite Campus Mitte, Klin Nephrol, Berlin, Germany
[3] Klinikum RWTH Aachen, Med Klin 2, Aachen, Germany
[4] Hannover Med Sch, Klin Nieren & Hochdruckkrankheiten, D-30623 Hannover, Germany
[5] Nephrol Univ Klinikum Dresden, Med Klin & Poliklin 3, Dresden, Germany
[6] Univ Klinikum Erlangen, Med Klin Nephrol & Hypertensiol 4, Erlangen, Germany
[7] Univ Klinikum Leipzig, Chirurg Klin & Poliklin Transplantat Ambulanz 2, Leipzig, Germany
[8] Univ Duisburg Essen, Klin Nephrol, Univ Klinikum Essen, Duisburg, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2011年 / 136卷 / 49期
关键词：
calcineurin inhibitor toxicity; mTOR inhibitor; sirolimus; chronic allograft nephropathy; EARLY CYCLOSPORINE WITHDRAWAL; ALLOGRAFT RECIPIENTS; KIDNEY-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; RAPAMYCIN INHIBITORS; MAINTENANCE THERAPY; PHASE-III; IMMUNOSUPPRESSION; EFFICACY; COMPLICATIONS;
D O I：
10.1055/s-0031-1292822
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2554 / 2559
页数：6
相关论文
共 62 条
  • [1] Altenburg A, 2008, Skin Therapy Lett, V13, P1
  • [2] [Anonymous], 2011, FACH RAP 05 MG 1 MG
  • [3] ANZDATA-The Australia and New Zealand Dialysis and Transplant Registry, 30 ANN REP 2007 REP
  • [4] Arns W, 2005, NIEREN HOCHDRUCK, V34, P551
  • [5] Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders
    Boratynska, Maria
    Smolska, Danuta
    [J]. TRANSPLANT INTERNATIONAL, 2008, 21 (06) : 605 - 608
  • [6] Higher exposure to mycophcnolic acid with sirohmus than with cyclosporine cotreatment
    Büchler, M
    Lebranchu, Y
    Bénéton, M
    Le Meur, Y
    Heng, AE
    Westeel, PF
    le Guellec, C
    Libert, F
    Hary, L
    Marquet, P
    Paintaud, G
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (01) : 34 - 42
  • [7] Budde K, 2009, AM J TRANSPLANT, V9, P259
  • [8] Sirolimus and ACE-inhibitors: A note of caution
    Burdese, M
    Rossetti, N
    Guarena, C
    Consiglio, V
    Mezza, E
    Soragna, G
    Gai, M
    Segoloni, GP
    Piccoli, GB
    [J]. TRANSPLANTATION, 2005, 79 (02) : 251 - 252
  • [9] Conversion to sirolimus: A successful treatment for posttransplantation Kaposi's sarcoma
    Campistol, JM
    Gutierrez-Dalmau, A
    Torregrosa, JV
    [J]. TRANSPLANTATION, 2004, 77 (05) : 760 - 762
  • [10] Use of proliferation signal inhibitors in the management of post-transplant malignancies -: clinical guidance
    Campistol, Josep M.
    Albanell, Joan
    Arns, Wolfgang
    Boletis, Ioannis
    Dantal, Jacques
    de Fijter, J. W.
    Mortensen, Svend Aage
    Neumayer, Hans-Hellmut
    Oyen, Ole
    Pascual, Julio
    Pohanka, Erich
    Schena, F. Paolo
    Seron, Daniel
    Sparacino, Vito
    Chapman, Jeremy R.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : I36 - I41
1234567